In summary, this manuscript aims to comprehensively explore the multifaceted aspects of CTCL, from the immunopathogenesis and cytokine dynamics centred around TNF-α and IFN-γ to evolving therapeutic modalities. The gene discussed is TNF; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.